JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB253016

Anti-Elongation of very long chain fatty acids protein 3 antibody

Be the first to review this product! Submit a review

|

(1 Publication)

Rabbit Polyclonal Elongation of very long chain fatty acids protein 3 antibody. Suitable for IHC-P, ICC/IF and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Recombinant Fragment Protein within Human ELOVL3 aa 1-50.

View Alternative Names

CIG30, ELOVL3, Very long chain fatty acid elongase 3, 3-keto acyl-CoA synthase ELOVL3, Cold-inducible glycoprotein of 30 kDa, ELOVL fatty acid elongase 3, Elongation of very long chain fatty acids protein 3, Very long chain 3-ketoacyl-CoA synthase 3, Very long chain 3-oxoacyl-CoA synthase 3, ELOVL FA elongase 3

5 Images
Immunocytochemistry/ Immunofluorescence - Anti-Elongation of very long chain fatty acids protein 3 antibody (AB253016)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-Elongation of very long chain fatty acids protein 3 antibody (AB253016)

PFA-fixed, Triton X-100 permeabilized SiHa (Human cervical carcinoma cell line) cells stained for Elongation of very long chain fatty acids protein 3 (green) using ab253016 at 4 μg/ml in ICC/IF.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Elongation of very long chain fatty acids protein 3 antibody (AB253016)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Elongation of very long chain fatty acids protein 3 antibody (AB253016)

Formalin-fixed, paraffin-embedded human tonsil tissue shows absence of immunoreactivity for ELOVL3 when incubated with ab253016 at a 1/2500 dilution (negative control).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Elongation of very long chain fatty acids protein 3 antibody (AB253016)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Elongation of very long chain fatty acids protein 3 antibody (AB253016)

Formalin-fixed, paraffin-embedded human liver tissue shows absence of immunoreactivity for ELOVL3 when incubated with ab253016 at a 1/2500 dilution (negative control).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Elongation of very long chain fatty acids protein 3 antibody (AB253016)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Elongation of very long chain fatty acids protein 3 antibody (AB253016)

Formalin-fixed, paraffin-embedded human skin tissue stained for ELOVL3 with ab253016 at a 1/2500 dilution in immunohistochemical analysis.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Elongation of very long chain fatty acids protein 3 antibody (AB253016)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Elongation of very long chain fatty acids protein 3 antibody (AB253016)

Formalin-fixed, paraffin-embedded human pancreas tissue shows absence of immunoreactivity for ELOVL3 when incubated with ab253016 at a 1/2500 dilution (negative control).

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

ICC/IF, IHC-P

applications

Immunogen

Recombinant Fragment Protein within Human ELOVL3 aa 1-50. The exact immunogen used to generate this antibody is proprietary information.

Q9HB03

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/2500 - 1/5000", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "0.25-2 µg/mL", "ICCIF-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7.2 Preservative: 0.02% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine)
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Elongation of very long chain fatty acids protein 3 also known as ELOVL3 is involved in the elongation process of fatty acids. It is a member of the endoplasmic reticulum membrane-bound proteins responsible for extending saturated and monounsaturated fatty acids with 18 to 24 carbons. With a molecular mass of approximately 31 kDa ELOVL3 is expressed strongly in tissues related to lipid metabolism such as liver brown adipose tissue and skin. This distribution displays its role in organisms’ overall lipid homeostasis.
Biological function summary

The synthesis and regulation of very long chain fatty acids rely heavily on ELOVL3. The protein is part of a complex that includes other elongation enzymes important for lipid metabolism. Through its action in lipid biosynthesis ELOVL3 plays an essential role in maintaining cellular membrane integrity and signaling molecules that rest within the lipid categories. This underlines its importance in energy storage and consumption particularly in adipose tissues where it contributes to the synthesis of lipids necessary for efficient thermal insulation and protection.

Pathways

Long chain fatty acid metabolism places significant importance on ELOVL3. It aligns itself within the fatty acid elongation pathway which serves as an integral section of the overall lipid metabolism pathway. This process involves interaction with other elongase proteins like ELOVL1 revealing a network of collaborative pathway members performing tasks necessary for elongating fatty acids properly. This elongation impacts processes like synthesis of essential neutral lipids and the development of ceramides that affect cellular communication.

Particular implications for ELOVL3 exist in metabolic conditions specifically in disorders such as Ichthyosis and Adrenoleukodystrophy. Misregulation or mutation of ELOVL3 can lead to abnormal lipid profiles in affected tissues contributing to these diseases. For instance disturbances in ELOVL3 activity alter the formation of lipid components that impair skin barrier function which is key for Ichthyosis. Connections with proteins such as ABCD1 involved in Adrenoleukodystrophy reveal how alterations in pathways concerning ELOVL3 influence disease progression further illustrating how dysfunction impacts human health.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Catalyzes the first and rate-limiting reaction of the four reactions that constitute the long-chain fatty acids elongation cycle. This endoplasmic reticulum-bound enzymatic process allows the addition of 2 carbons to the chain of long- and very long-chain fatty acids (VLCFAs) per cycle. Condensing enzyme that exhibits activity toward saturated and unsaturated acyl-CoA substrates with higher activity toward C18 acyl-CoAs, especially C18 : 0 acyl-CoAs. May participate in the production of saturated and monounsaturated VLCFAs of different chain lengths that are involved in multiple biological processes as precursors of membrane lipids and lipid mediators.
See full target information ELOVL3

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

European journal of clinical investigation 51:e13541 PubMed33797091

2021

Circ_0007142 downregulates miR-874-3p-mediated GDPD5 on colorectal cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Yueqing Wang,Hongshu Chen,Xueling Wei
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com